Cite

HARVARD Citation

    Middelkoop, M. et al. (2022). Evaluation of marketing authorization and clinical implementation of ulipristal acetate for uterine fibroids. Human reproduction. 37 (5), pp. 884-894. [Online]. 
  
Back to record